Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Pantheon International director raises stake

(Sharecast News) - Pantheon International revealed on Thursday that non-executive director John Burgess had acquired 166,038 ordinary shares in the FTSE 250-listed investment trust. Burgess, who made the purchase via his interest in The November 1990 Trust, snapped up the shares at an average price of 324.65p each, for a total value of £539,047.48.

As of 1620 BST, Pantheon shares were flat at 323.50p.

Reporting by Iain Gilbert at Sharecast.com

Top Director Buys

Pantheon International (PIN) Director name: Burgess ,John Amount purchased: 166,038 @ 324.65p Value: £539,047.48

Staffline Group (STAF) Director name: Spain,Thomas Amount purchased: 101,266 @ 35.55p Value: £36,000.06

Hydrogen Utopia International (HUI) Director name: White,Howard Amount purchased: 500,000 @ 4.88p Value: £24,400.00

Seed Innovations Limited (SEED) Director name: Jersey,Lance De Amount purchased: 1,000,000 @ 1.45p Value: £14,500.00

Top Director Sells

Bloomsbury Publishing (BMY) Director name: Newton,Nigel Amount sold: 58,378 @ 713.30p Value: £416,410.27

Bloomsbury Publishing (BMY) Director name: Scott-Bayfield,Penny Amount sold: 38,085 @ 713.30p Value: £271,660.30

Staffline Group (STAF) Director name: Spain,Thomas Amount sold: 101,266 @ 35.55p Value: £36,000.06

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 600 @ $4.30 Value: $2,127.48

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 400 @ $4.26 Value: $1,403.48

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 400 @ $4.23 Value: $1,395.23

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 301 @ $4.27 Value: $1,059.84

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 296 @ $4.31 Value: $1,052.00

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 300 @ $4.23 Value: $1,046.43

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 206 @ $4.23 Value: $718.55

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 200 @ $4.35 Value: $717.41

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 152 @ $4.28 Value: $536.46

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 87 @ $4.29 Value: $307.77

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 58 @ $4.26 Value: $203.98

Share this article

Related Sharecast Articles

Director dealings: Celebrus Technologies CFO raises stake
(Sharecast News) - Celebrus Technologies revealed on Thursday that chief financial office Ashoni Mehta had acquired 60,000 ordinary shares in the AIM-listed data solutions provider.
Director dealings: Vistry CEO snaps up shares
(Sharecast News) - Vistry Group revealed on Wednesday that chief executive Adam Daniels had acquired 38,372 ordinary shares in the FTSE 250-listed housebuilder.
Director dealings: SysGroup executive chairman ups shareholding
(Sharecast News) - SysGroup revealed on Tuesday that executive chairman Heejae Chae had acquired 416,639 ordinary shares in the AIM-listed IT services provider.
Director dealings: Cloudcoco chairman raises stake
(Sharecast News) - Cloudcoco revealed on Monday that chairman Simon Duckworth had acquired 7.5m ordinary shares in the AIM-listed e-commerce and IT procurement group.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.